BLTP3A is associated with membranes of the late endocytic pathway and is an effector of CASM.

Saved in:
Bibliographic Details
Title: BLTP3A is associated with membranes of the late endocytic pathway and is an effector of CASM.
Authors: Hanna MG; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA. michael.hanna@yale.edu.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA. michael.hanna@yale.edu.; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA. michael.hanna@yale.edu.; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA. michael.hanna@yale.edu.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA. michael.hanna@yale.edu., Rodriguez Cruz HO; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA., Fujise K; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA., Wu Y; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA., Xu CS; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA., Pang S; Yale University School of Medicine, New Haven, CT, USA., Li Z; Proteomics Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Monetti M; Proteomics Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., De Camilli P; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA. pietro.decamilli@yale.edu.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA. pietro.decamilli@yale.edu.; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA. pietro.decamilli@yale.edu.; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA. pietro.decamilli@yale.edu.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA. pietro.decamilli@yale.edu.
Source: The EMBO journal [EMBO J] 2025 Nov; Vol. 44 (21), pp. 6168-6195. Date of Electronic Publication: 2025 Sep 11.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2075
DOI:10.1038/s44318-025-00543-9